Jazz Pharmaceuticals (JAZZ) 10-K2010 FY Annual report

Filed: 8 Mar 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Abbott, aimed, AMP, API, Biomedical, Blood, buyer, category, causal, ceiling, Cincinnati, clotting, CMS, contest, Cox, CRL, database, debilitating, DesJardin, destruction, donut, Dow, Dr, Eller, Engineer, Engineering, Eurodollar, external, feedback, GAAP, gap, Genentech, Heart, Hoechst, hole, Hormone, Implant, insignificant, instance, Iowa, Ipsen, isolation, Jersey, kickback, Leader, Lung, machinery, Marion, meant, Merrell, nationwide, newer, orderly, passed, Paul, permission, pertain, pipelinethough, plc, prepaid, PTL, Roussel, Roxane, Russell, Science, seller, Siegfried, signal, smoothly, solid, spent, teaching, Tercica, theft, today, unamortized, underwritten, undrawn, uninsured, Upjohn, vi, voucher, window

Removed: absorption, acceptability, accrual, accrue, administering, adolescent, adult, agonist, analog, analyst, analytical, announcement, annualized, anticonvulsant, antidilutive, antiepileptic, approach, attestation, attributable, authorize, avoidance, baggage, base, baseline, Bay, Beecham, begin, billed, bipolar, bowel, broadly, build, cancelled, catastrophic, cease, centralized, chemistry, classification, classified, clinically, clock, collaborate, collecting, combined, commenced, commerce, compound, comprehensively, contracted, convincing, cooperation, count, culture, Cystadane, dating, dba, deadline, dedicate, deliberate, delivering, demonstrating, depression, designing, destination, detailing, deterioration, disadvantage, disaster, discontinuation, dispersed, disruption, dissatisfaction, distinctive, distributing, dollar, dominant, dopamine, duloxetine, dysfunction, earn, earthquake, economy, educational, Eli, emerging, employer, ending, endpoint, enjoined, enjoyed, entry, estate, ethical, Euro, everyday, exceeded, excluding, excretion, executed, execution, expedited, expiry, expose, expressing, facilitate, failed, fault, fear, feel, felony, fill, fire, flexibility, fluctuating, fomepizole, formulated, Foundation, Francisco, fraudulent, frequently, functional, functioning, gamma, gel, geographically, Glaxo, GlaxoSmithKline, guilty, halted, headcount, healthy, hired, hold, hundred, hydroxybutyrate, hypertension, hypothetical, IIa, IIb, impacted, imported, impression, improvement, improving, incidence, incorporating, infection, inhibitor, inNeurologic, institution, intensive, intention, interaction, internet, interstate, invalidity, investigating, investigator, IRB, issuable, JPIC, labeled, Lamictal, lamotrigine, largely, largest, LB, left, Liebowitz, light, likelihood, Lilly, liquidated, lowest, machine, mail, measurement, mechanism, metabolism, metabolized, milnacipran, misbranded, mitigate, Modernization, nausea, negotiate, neutral, newly, night, Notwithstanding, nursing, objected, offered, operational, optimal, outlined, overcome, overlap, pathway, people, peripheral, permanently, personal, Pfizer, pharmacodynamic, pharmacologic, placebo, pled, polypharmacy, pregabalin, premium, prepare, preserve, presidential, presumption, proceed, profit, prohibition, proven, pursued, questionnaire, reaching, reacquire, recurrent, reducing, reformulate, registry, reimported, relieve, relinquish, remained, remit, rendered, rental, resolve, resource, Restoration, restructuring, retained, rolling, ropinirole, San, sanction, score, scrutinize, securing, sequential, servicing, settled, sexual, situation, skip, SmithKline, sNDA, spread, SSRI, Sterling, stockpiling, strict, subpopulation, subsidiary, suggest, suicidal, summarizing, superior, supported, tablet, temporarily, tested, therapy, thought, thousand, tolerability, tolerance, traditional, training, Tranche, transdermal, transition, trauma, treating, treble, trinet, typical, ultimate, unacceptable, underdiagnosed, undertreated, unexpected, unpaid, unreasonable, unrecoverable, unsalable, variability, vested, violation, visual, vomiting, vulnerable, week, weight, weighted, whistleblower, withdrawn

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

JAZZ similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 10.55

2010 and 2011 Executive Officer Compensation Arrangements


Executive Officer	2010 Base Salary Rate⁽¹⁾		2010 Target Bonus as % of Annual Base Salary Rate		2011 Base Salary Rate⁽²⁾		2011 Target Bonus as % of Annual Base Salary Rate
Bruce C. Cozadd	$	500,000		60	$	575,000		65
Chairman and Chief Executive Officer

Russell J. Cox⁽³⁾⁽⁴⁾	$	260,000		20-35	$	325,000		40
Senior Vice President, Sales and Marketing

Michael A. DesJardin	$	285,000		40	$	288,000		40
Senior Vice President, Product Development

Mark G. Eller, Ph.D.	$	280,000		40	$	288,000		40
Senior Vice President, Research and Clinical Development

Kathryn E. Falberg	$	365,000		40	$	380,000		40
Senior Vice President and Chief Financial Officer

Carol A. Gamble	$	361,000		40	$	362,000		40
Senior Vice President, General Counsel and Corporate Secretary

Robert M. Myers⁽⁵⁾	$	448,000		50		—		—
President

Janne L. T. Wissel	$	361,000		40	$	362,000		40
Senior Vice President, Chief Regulatory and Compliance Officer

Joan E. Colligan	$	217,250		10-30	$	217,250		10-30
Controller and Principal Accounting Officer

(1)	Base salary rate beginning March 1, 2010.

(2)	Base salary rate beginning March 1, 2011.

(3)	Mr. Cox joined the company as Vice President of Marketing on July 21, 2010.

(4)	Mr. Cox became Senior Vice President, Sales and Marketing effective January 7, 2011 and his base salary rate, as of that date until March 1, 2011, was increased to $315,000.

(5)	Mr. Myers resigned as President effective January 14, 2011. In connection with his resignation, Mr. Myers and the company entered into a separation agreement.